Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Comparison of elderly and young patient populations treated with deep brain stimulation for Parkinson's disease: long-term outcomes with up to 7 years of follow-up.

Hanna JA, Scullen T, Kahn L, Mathkour M, Gouveia EE, Garces J, Evans LM, Lea G, Houghton DJ, Biro E, Bui CJ, Sulaiman OA, Smith RD.

J Neurosurg. 2018 Sep 28:1-6. doi: 10.3171/2018.4.JNS171909. [Epub ahead of print]

PMID:
30265192
2.

A comparison of LEDD and motor scores following STN-DBS treatment in patient with young onset vs. late onset Parkinson's disease.

Park YS, Kim HY, Chang WS, Lee PH, Sohn YH, Chang JW.

Neuromodulation. 2010 Oct;13(4):255-60. doi: 10.1111/j.1525-1403.2009.00273.x.

PMID:
21992878
3.

Short- and Long-Term Outcomes of Deep Brain Stimulation in Patients 70 Years and Older with Parkinson Disease.

Mathkour M, Garces J, Scullen T, Hanna J, Valle-Giler E, Kahn L, Arrington T, Houghton D, Lea G, Biro E, Bui CJ, Sulaiman OA, Smith RD.

World Neurosurg. 2017 Jan;97:247-252. doi: 10.1016/j.wneu.2016.06.001. Epub 2016 Jun 11.

PMID:
27297246
4.

Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization.

Garcia-Garcia D, Guridi J, Toledo JB, Alegre M, Obeso JA, Rodríguez-Oroz MC.

J Neurosurg. 2016 Nov;125(5):1068-1079. Epub 2016 Feb 5.

PMID:
26848922
5.

Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.

Yamamoto T, Uchiyama T, Higuchi Y, Asahina M, Hirano S, Yamanaka Y, Kuwabara S.

PLoS One. 2015 Sep 22;10(9):e0138462. doi: 10.1371/journal.pone.0138462. eCollection 2015.

6.

Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.

Senova S, Hosomi K, Gurruchaga JM, Gouello G, Ouerchefani N, Beaugendre Y, Lepetit H, Lefaucheur JP, Badin RA, Dauguet J, Jan C, Hantraye P, Brugières P, Palfi S.

J Neurosurg. 2016 Aug;125(2):472-80. doi: 10.3171/2015.7.JNS15379. Epub 2016 Jan 8.

PMID:
26745490
7.

Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.

Chen T, Mirzadeh Z, Chapple KM, Lambert M, Shill HA, Moguel-Cobos G, Tröster AI, Dhall R, Ponce FA.

J Neurosurg. 2018 Mar 16:1-12. doi: 10.3171/2017.8.JNS17883. [Epub ahead of print]

PMID:
29547091
8.

Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.

Ostrem JL, Ziman N, Galifianakis NB, Starr PA, Luciano MS, Katz M, Racine CA, Martin AJ, Markun LC, Larson PS.

J Neurosurg. 2016 Apr;124(4):908-16. doi: 10.3171/2015.4.JNS15173. Epub 2015 Oct 23.

PMID:
26495947
9.

Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.

Liu Y, Li W, Tan C, Liu X, Wang X, Gui Y, Qin L, Deng F, Hu C, Chen L.

J Neurosurg. 2014 Sep;121(3):709-18. doi: 10.3171/2014.4.JNS131711. Epub 2014 Jun 6.

PMID:
24905564
10.

SW2-year outcomes of subthalamic deep brain stimulation for idiopathic Parkinson's disease.

Nunta-Aree S, Sitthinamsuwan B, Boonyapisit K, Pisarnpong A.

J Med Assoc Thai. 2010 May;93(5):529-40.

PMID:
20524438
11.

The effect of dopaminergic therapy on intraoperative microelectrode recordings for subthalamic deep brain stimulation under GA: can we operate on patients 'on medications'?

Asha MJ, Kausar J, Krovvidi H, Shirley C, White A, Chelvarajah R, Hodson JA, Pall H, Mitchell RD.

Acta Neurochir (Wien). 2016 Feb;158(2):387-93. doi: 10.1007/s00701-015-2631-1. Epub 2015 Nov 25.

PMID:
26602236
12.

Prediction of depression and anxiety via patient-assessed tremor severity, not physician-reported motor symptom severity, in patients with Parkinson's disease or essential tremor who have undergone deep brain stimulation.

Achey RL, Yamamoto E, Sexton D, Hammer C, Lee BS, Butler RS, Thompson NR, Nagel SJ, Machado AG, Lobel DA.

J Neurosurg. 2018 Feb 23:1-10. doi: 10.3171/2017.8.JNS1733. [Epub ahead of print]

PMID:
29473781
13.

Different effectiveness of subthalamic deep brain stimulation in Parkinson's disease: A comparative cohort study at 1 year and 5 years.

Jiang JL, Chen SY, Hsieh TC, Lee CW, Lin SH, Tsai ST.

J Formos Med Assoc. 2015 Sep;114(9):835-41. doi: 10.1016/j.jfma.2013.09.006. Epub 2013 Oct 6.

14.

Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.

Lezcano E, Gómez-Esteban JC, Tijero B, Bilbao G, Lambarri I, Rodriguez O, Villoria R, Dolado A, Berganzo K, Molano A, de Gopegui ER, Pomposo I, Gabilondo I, Zarranz JJ.

J Neurol. 2016 May;263(5):895-905. doi: 10.1007/s00415-016-8077-4. Epub 2016 Mar 10.

PMID:
26964542
15.

Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease.

Kim JH, Chang WS, Jung HH, Chang JW.

Yonsei Med J. 2015 Sep;56(5):1316-21. doi: 10.3349/ymj.2015.56.5.1316.

16.

Bilateral subthalamic deep brain stimulation is an effective and safe treatment option for the older patients with Parkinson's disease.

Kim M, Cho KR, Park JH, Ahn JH, Cho JW, Park S, Lee JI, Youn J.

Clin Neurol Neurosurg. 2018 Oct;173:182-186. doi: 10.1016/j.clineuro.2018.08.025. Epub 2018 Aug 14.

PMID:
30149306
17.

Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus.

Mirzadeh Z, Chapple K, Lambert M, Evidente VG, Mahant P, Ospina MC, Samanta J, Moguel-Cobos G, Salins N, Lieberman A, Tröster AI, Dhall R, Ponce FA.

J Neurosurg. 2016 Apr;124(4):902-7. doi: 10.3171/2015.4.JNS1550. Epub 2015 Oct 9.

PMID:
26452116
18.

Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease.

Kleiner-Fisman G, Fisman DN, Sime E, Saint-Cyr JA, Lozano AM, Lang AE.

J Neurosurg. 2003 Sep;99(3):489-95.

PMID:
12959435
19.

Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.

Liang GS, Chou KL, Baltuch GH, Jaggi JL, Loveland-Jones C, Leng L, Maccarone H, Hurtig HI, Colcher A, Stern MB, Kleiner-Fisman G, Simuni T, Siderowf AD.

Stereotact Funct Neurosurg. 2006;84(5-6):221-7. Epub 2006 Oct 23.

PMID:
17063043
20.

Long-term Efficacy of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease: A 5-year Follow-up Study in China.

Jiang LL, Liu JL, Fu XL, Xian WB, Gu J, Liu YM, Ye J, Chen J, Qian H, Xu SH, Pei Z, Chen L.

Chin Med J (Engl). 2015 Sep 20;128(18):2433-8. doi: 10.4103/0366-6999.164925.

Supplemental Content

Support Center